Aveanna Healthcare Raises 2026 Guidance on Strong Q1 Growth
Event summary
- Aveanna Healthcare reported Q1 2026 revenue of $647.9 million, up 15.9% YoY.
- Net income surged to $41.7 million from $5.2 million in the prior year period.
- Adjusted EBITDA increased by 25.2% YoY to $84.4 million.
- Full-year 2026 revenue guidance raised to $2.56–$2.58 billion from $2.54–$2.56 billion.
- Adjusted EBITDA guidance for 2026 increased to $328–$332 million from $318–$322 million.
The big picture
Aveanna Healthcare's strong Q1 2026 results reflect the resilience of its care model and strategic focus on high-cost patient populations. The company's raised guidance underscores its ability to capitalize on organic growth opportunities, even as it navigates regulatory uncertainties and integrates a significant acquisition. The home care sector continues to expand, driven by demographic shifts and a preference for lower-cost alternatives to hospitalization.
What we're watching
- Regulatory Headwinds
- The impact of the One Big Beautiful Bill Act and other regulatory changes on Aveanna's reimbursement rates and operational costs.
- Acquisition Integration
- The successful integration of Family First Homecare and its effect on Aveanna's liquidity and operational efficiency.
- Market Competition
- How Aveanna will maintain its growth momentum amidst intense competition in the home health and hospice sectors.
Related topics